Serum irisin: Pathogenesis and clinical research in cardiovascular diseases

March 19, 2020

In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0569, Lutfu Askin, Kader Eliz Uzel, Okan Tanriverdi and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider serum irisin pathogenesis and clinical research in cardiovascular diseases.

The authors summarize studies on the role of serum irisin levels in the process of atherosclerosis and other cardiovascular events in cardiovascular diseases. Irisin is a recently discovered molecule produced by muscles. It has been shown to be associated with different metabolic markers. Current studies suggest that irisin is a promising therapeutic agent in diseases such as DM, metabolic syndrome, and CVDs.
-end-
CVIA is available on the IngentaConnect platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. CVIA is indexed in the EMBASE, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Cardiovascular Innovations and Applications

Related Metabolic Syndrome Articles from Brightsurf:

Metabolic syndrome linked to worse outcomes for COVID-19 patients
Patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity and diabetes were over three times more likely to die from the disease, according to a new Tulane University study published in Diabetes Care.

New study finds that menopause increases risk of metabolic syndrome
Perimenopause is a time when women become more vulnerable to a number of health problems.

Does sarcoponic obesity link to metabolic syndrome? An issue that needs clarification
A systematic review and meta-analysis with the main scope to provide benchmark data on the prevalence of metabolic syndrome (Mets) among individuals with Sarcopenic Obesity (SO), as well as to detect the potential association between the presence of SO and the higher risk of Mets.

Socioeconomics, metabolic syndrome, and osteopenia in postmenopausal women
The increased prevalence of metabolic syndrome and osteoporosis in postmenopausal women has prompted multiple research studies to understand why.

Metabolic syndrome associated with increased risk of blood clot recurrence
People with metabolic syndrome -- a set of conditions including obesity, impaired glucose metabolism, elevated levels of fats and cholesterol in the blood, and high blood pressure - are more likely to experience recurrent blood clots, according to a new study published today in Blood Advances.

Hops compounds help with metabolic syndrome while reducing microbiome diversity
Compounds from hops may combat metabolic syndrome by changing the gut microbiome and altering the metabolism of acids produced in the liver, new research suggests.

Metabolic syndrome: New use for an old drug
The discovery, described in a study by Cosbi and Cimec of the University of Trento published today in Nature Communications, confirms the effectiveness of repurposing, the new frontier of pharmacological research.

Three easy measures to predict metabolic syndrome in elderly
A new study found a surprisingly high rate of metabolic syndrome among individuals aged 60-100 years.

Nanovaccine boosts immunity in sufferers of metabolic syndrome
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

Natural sugar defends against metabolic syndrome, in mice
New research, in mice, indicates that a natural sugar called trehalose blocks glucose from the liver and activates a gene that boosts insulin sensitivity, reducing the chance of developing diabetes.

Read More: Metabolic Syndrome News and Metabolic Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.